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Abstract Although reverse cholesterol transport from pe-
ripheral cell types is mediated through plasma membrane
microdomains termed lipid rafts, almost nothing is known
regarding the existence, protein/lipid composition, or struc-
ture of these putative domains in liver hepatocytes, cells
responsible for the net removal of cholesterol from the body.
Lipid rafts purified from hepatocyte plasma membranes by a
nondetergent affinity chromatography method were: i) pres-
ent at 336 3%of total plasmamembraneprotein; ii) enriched
in key proteins of the reverse cholesterol pathway [scavenger
receptor class B type I (SR-B1), ABCA1,P-glycoprotein (P-gp),
sterol carrier protein-2 (SCP-2)]; iii) devoid of caveolin-1; iv)
enriched in cholesterol, sphingomyelin, GM1, and phospho-
lipids low in polyunsaturated fatty acid and double bond
index; and v) exhibited an intermediate liquid-ordered lipid
phase with significant transbilayer fluidity gradient. Ablation
of the gene encoding SCP-2 significantly altered lipid rafts
to: i) increase the proportion of lipid rafts present, thereby
increasing raft total content of ABCA1, P-gp, and SR-B1; ii)
increase total phospholipids while decreasing GM1 in lipid
rafts; iii) decrease the fluidity of lipid rafts, consistent with
the increased intermediate liquid-ordered phase; and iv)
abolish the lipid raft transbilayer fluidity gradient. Thus,
despite the absence of caveolin-1 in liver hepatocytes, lipid
rafts represented nearly one-third of the mouse hepatocyte
plasma membrane proteins and displayed unique protein,
lipid, and biophysical properties that were differentially regu-
lated by SCP-2 expression.—Atshaves, B. P., A. L. McIntosh,
H. R. Payne, A. M. Gallegos, K. Landrock, N. Maeda, A. B.
Kier, and F. Schroeder. SCP-2/SCP-x gene ablation alters
lipid raft domains in primary cultured mouse hepatocytes.
J. Lipid Res. 2007. 48: 2193–2211.
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Although all cells synthesize cholesterol, only liver and
steroidogenic tissues effect net cholesterol removal. Re-
verse cholesterol transport (RCT) from peripheral tissues
to liver for oxidation and excretion is the major physio-
logical pathway for the net cholesterol elimination from the
body. Although increasing evidence indicates that plasma
membrane microdomains, termed lipid rafts/caveolae,
compartmentalize cell surface proteins that mediate HDL-
cholesterol uptake/efflux in peripheral cells, the existence
and/or significance of such domains in hepatocyte plasma
membranes is not completely clear, especially in view of
the nearly negligible levels of caveolin-1 in liver. However,
an overall scheme is beginning to evolve based largely on
findings with peripheral cells (reviewed in Ref. 1).
First, peripheral cells (fibroblasts, muscle, and endo-
thelial cells) are rich in both lipid rafts and caveolae
(a subset of lipid rafts rich in several components of the
RCT pathway) but are relatively poor in intracellular cho-
lesterol binding proteins such as sterol carrier protein-2
(SCP-2) that facilitate cholesterol retention rather than
efflux (reviewed in Refs. 1, 2). Cholesterol effluxes from
peripheral cells to HDL by a process facilitated by: i) the
HDL receptor scavenger receptor class B type I (SR-B1)
(3); ii) ABCA1, a protein that mediates cholesterol and
phosphatidylcholine desorption from the plasma mem-
brane to apolipoprotein A-I (apoA-I) in the plasma,
thereby leading to the formation of HDL (4); and iii) P-
glycoprotein (P-gp), a protein thought to translocate cho-
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lesterol from the cytofacial to the exofacial leaflet of the
plasmamembrane, facilitatingcholesteroleffluxtoHDL(5).
Second, although HDL transports cholesterol and cho-
lesteryl ester through the vasculature to liver hepatocytes
for uptake, it is unclear at present whether this process is
mediated through putative lipid rafts in the hepatocyte
plasma membrane. In addition, although liver expresses
SR-B1, ABCA1, and P-gp, it is not known whether: i) hepa-
tocyte plasma membranes contain lipid rafts; ii) caveolin-
1, highly expressed in liver nonparenchymal cells (e.g.,
endothelial, stellate, and Kupffer cells), is present in the
putative hepatocyte lipid rafts; or iii) proteins essential
for HDL-mediated cholesterol/cholesteryl ester transport
(SR-B1, ABCA1, and P-gp) are present in the putative he-
patocyte lipid rafts.
Third, hepatocytes are essentially deficient in caveolin-
1 (6–8) but rich in cholesterol binding/transport pro-
teins, including SCP-2 [also liver fatty acid binding
protein (L-FABP)], which enhance cholesterol uptake,
intracellular retention (esterification), and transport for
secretion into bile (reviewed in Ref. 1). Because HDL-
mediated cholesterol transport is bidirectional, hepato-
cytes contain a complement of proteins that not only
facilitate efficient cholesterol transport into hepatocytes
but also prevent retrograde efflux of cholesterol out of
the hepatocyte. Recent real-time fluorescence imaging of
sterol transport (9) as well as other studies indicate that
hepatocyte intracellular cholesterol transport for secre-
tion into bile is protein-mediated rather than vesicular
(reviewed in Ref. 1). Because caveolin-1 is very low/
absent in hepatocytes, two other cholesterol binding pro-
teins have been proposed as serving in intracellular
cholesterol transport: SCP-2 and L-FABP (reviewed in
Ref. 1). In vitro and intact cell studies show that SCP-2
enhances sterol transfer from the plasma membrane to
the endoplasmic reticulum and to other intracellular
membranes, whereas L-FABP more weakly enhances ste-
rol transfer (reviewed in Ref. 10).
The purpose of the present investigation was to demon-
strate: i) the existence of lipid rafts in hepatocyte plasma
membranes; ii) the compartmentalization of RCT proteins
therein; iii) the unique lipid distribution and structural
properties of hepatocyte lipid rafts; iv) how these prop-
erties of hepatocyte lipid rafts differ from those of nonraft
domains; and v) whether the cholesterol binding/transfer
protein SCP-2 differentially regulates intrinsic properties
of hepatocyte lipid rafts. These issues were addressed by
the successful application of an affinity chromatography
method (11–14) used for the first time on mouse hepa-
tocyte primary cell cultures to simultaneously isolate lipid
rafts and nonrafts from purified plasma membranes
(derived from wild-type and SCP-2/SCP-x gene-ablated
mice) without the use of detergents or high-pH carbonate
buffers. In addition, the data showed for the first time that,
despite the near absence of caveolin-1 in liver, lipid rafts
comprise a substantial portion (nearly one-third based
on protein) of the hepatocyte plasma membrane, are en-
riched in key proteins mediating RCT, and exhibit unique
lipid composition and structure compared with nonrafts,




Concanavalin A (ConA) Sepharose resin was purchased from
Pharmacia (Piscataway, NJ). Neutral lipid and fatty acid standards
were purchased from Nu-Chek Prep, Inc. (Elysian, MN). Phos-
pholipid standards were obtained from Avanti (Alabaster, AL).
Silica Gel G and Silica Gel 60 TLC plates were from Analtech
(Newark, DE) and EM Industries, Inc. (Darmstadt, Germany),
respectively. Rabbit polyclonal antisera to recombinant human
SCP-2 were prepared as described previously (15). Rabbit poly-
clonal antisera to caveolin-1, endothelial nitric oxide synthase
(eNOS), and flotillin were from BD Transduction Laboratories
(Palo Alto, CA). Rabbit anti-SR-B1 and anti-ABCA1 were from
Novus Biologicals (Littleton, CO). Rabbit anti-cholera toxin B
and anti-Gqa were from Sigma (St. Louis, MO). Rabbit anti-
CXCR4 was purchased from Abcam (Cambridge, MA). Rabbit
anti-MDR (P-gp) was from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). Lowicryl HM20 resin and goat anti-rabbit IgG con-
jugated to 15 nm gold were from Electron Microscopy Sciences
(Fort Washington, PA). 1,6-Diphenyl-1,3,5-hexatriene (DPH), 1,6-
diphyenyl-1,3,5-hexatrienyl-trimethylammonium (DPH-TMA),
3(1,6-diphenyl-1,3,5-hexatrienyl)-propionic acid (DPH-Pro),
9Z,11E,13E,15Z-octatetradecanoic acid (cis-parinaric acid), and
12-(N-methyl)-N-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]octa-
decanoic acid (NBD-stearic acid) were from Molecular Probes
(Eugene, OR). Dehydroergosterol (DHE) was synthesized in our
laboratory as described previously (16). All reagents and solvents
used were of the highest grade available and were cell culture tested.
Animals
All animal protocols were approved by the Institutional Ani-
mal Care and Use Committee at Texas A&M University. Male and
female (6 weeks old, 20–30 g) inbred C57BL/6NCr mice were
obtained from the National Cancer Institute (Frederick Cancer
Research and Developmental Center, Frederick, MD). SCP-2/
SCP-x gene-ablated mice were generated as described below. All
mice were kept under a 12 h light/dark cycle in a temperature-
controlled facility (25jC) with access to food (standard rodent
chow mix, 5% fat calories) and water ad libitum. Animals in the
facility were monitored quarterly for infectious diseases.
Generation of SCP-2/SCP-x gene-ablated mice
SCP-2/SCP-x gene-ablated mice were generated by targeted
disruption of the SCP-2 gene through homologous recombi-
nation. The targeting construct was designed to replace exon
16 with the neomycin cassette of the pUnivec-HPRT vector (a
generous gift from Dr. Ramiro Ramı́rez-Solis, Department of
Molecular and Human Genetics, Baylor College of Medicine,
Houston, TX). Briefly, a genomic 129/sv Lambda FIX: library
(Stratagene, La Jolla, CA) was screened with a 150 bp DNA
fragment containing exon 16 of the SCP-2/SCP-x gene. Positive
clones were confirmed by extensive restriction mapping and se-
quence analysis. Two consecutive genomic DNA fragments, a
2.0 kb PstI clone (containing intronic sequences upstream of
exon 16) and a 4.5 kb PstI clone (containing intronic sequences
immediately upstream of exon 16, exon 16 itself, and intronic
sequences downstream of exon 16) formed the backbone of the
targeting construct. The 3¶ homology arm was generated by
ligating a blunt-ended 2.6 kb XbaI fragment from the 4.5 kb PstI
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clone into Litmus 39 vector (New England Biolabs, Ipswich, MA)
predigested with EcoRV. This plasmid was digested with SacI/PstI
and ligated with an 875 bp fragment from the 4.5 kb PstI clone
digested with SacI/PstI. The resulting vector was digested with
BamHI/HindIII to give a 2,824 bp fragment that was ligated into
the pGEM-3Zf vector (Promega, Madison, WI) predigested with
BamHI/HindIII. Digestion with EcoRI/HindIII released the 3¶ ho-
mology region (with an incorporated KpnI site later used for
Southern blot screening). The 3¶ homology fragment was blunt-
ended with T4 DNA polymerase and ligated into the pUnivec-
HPRT vector (predigested with NotI and blunted with T4 DNA
ligase) to yield an intermediate targeting construct named
pUni13¶ vector. The 5¶ homology region was prepared by di-
gesting the 4.5 kb PstI clone with AccI/PstI to isolate a 2,562 bp
fragment that was then ligated to an AccI/PstI fragment isolated
from the 2.0 kb PstI clone. Digestion with BamHI/AccI released
the 5¶ homology fragment. The targeting construct was com-
pleted by blunt-end ligation of the 5¶ arm into the intermediate
construct pUni13¶ vector (predigested with NheI and then blunted
with T4 DNA polymerase).
Once complete, the targeting construct was opened with ClaI
and electroporated into a 129/Ola-derived embryonic stem cell
line E14 maintained on feeder layers. After selection with G418
(200 mg/ml) and gancyclovir (2 mM), DNA was isolated from
surviving clones, digested with KpnI, and screened by Southern
blot analysis according to standard protocols. Using a 200 bp 5¶
probe external to the targeting construct, targeted clones were
identified by the presence of a 6 kb band indicating that exon
16 was replaced with the neomycin cassette of pUnivec-HPRT
vector. Three positive clones were expanded and injected into
C57BL/6NCr blastocysts to create chimeric mice by standard
procedures. Three male chimeras were identified by coat color
and bred to C57BL/6NCr females to determine germline trans-
mission of the targeted allele. Tail DNA from mixed coat-colored
(agouti) F1 offspring was screened by PCR to verify the genotype
of each animal. Initial characterization of the SCP-2/SCP-x gene
ablation by Western analysis was performed on F2 SCP-22/2
homozygous mice generated by interbreeding heterozygous F1
animals. The heterozygous F1 animals were backcrossed to a N6
C57BL/6NCr background before interbreeding to produce the
SCP-2/SCP-x null mice used in this work.
Hepatocyte isolation and culture
Primary cultured hepatocytes derived from the livers of
12 week old male SCP-2/SCP-x null and wild-type mice were
isolated as described earlier (17). Primary hepatocytes cultured
for <4 days retain viability and function, as indicated by their
undiminished ability to synthesize and secrete albumin (17), syn-
thesize and secrete apolipoproteins (apoA-I, apoE1, and apoB),
synthesize L-FABP, secrete lipoproteins (VLDL and HDL), take
up fatty acid, transport fatty acid intracellularly, and oxidize fatty
acid (17, 18). Therefore, all experiments were performed with he-
patocytes maintained in culture for ,2 days, well within the range
established for retaining function and viability.
Lipid raft and nonraft isolation from primary
cultured hepatocytes
Lipid rafts and nonrafts were isolated from mouse hepatocyte
primary cell cultures by a nondetergent, affinity chromatogra-
phy method developed previously and applied to other cell types
(11–14). In brief, for each preparation, hepatocytes (7 3 106
cells/dish), cultured in 150 mm 3 25 mm Corning tissue culture
dishes (30 dishes; Corning and Costar, Corning, NY), were
washed two times with chilled PBS (4jC) and then scraped into
PBS containing protease inhibitor. The hepatocytes were then
sedimented at 1,000 g for 5 min (JA-12 conical rotor and Avanti
J-25 centrifuge; Beckman Instruments, Fullerton, CA) at 4jC fol-
lowed by resuspension in 12 ml of buffer A (0.25 M sucrose
and 5 mM Tris-HCl, pH 7.8, 4jC) and disruption with 40 p.s.i.
of N2 for 13 min in an N2 Bomb Cell Disrupter (Parr Instrument
Co., Moline, IL). The postnuclear supernatant was collected after
centrifugation, placed on top of 30% Percoll in sucrose/Tris
(4jC), and centrifuged at 70,000 g for 30 min (SW40Ti rotor and
XL90 ultracentrifuge; Beckman Instruments) at 4jC as described
previously (12). The plasma membrane-enriched fraction, located
at the interphase between the Percoll and sample layers, was iden-
tified by screening all of the visible protein bands separated by
the Percoll gradient for the presence of plasma membrane protein
markers (transferrin receptor, SR-B1, and Na1K1-ATPase). Once
collected, the enriched plasma membrane fraction was sonicated
by three brief 15 s pulses over 3 min with a Fisher 550 Sonic
Dismembrator (Fisher Scientific, Pittsburgh, PA) to break up large
sheets of plasma membrane. As shown previously by electron
microscopy, the disrupted plasma membranes appeared as vesi-
cles (average diameter of 99 nm) or as smaller, broken structures
(14). The sonicated plasma membrane fraction was then mixed
with ConA Sepharose resin (100 ml) in buffer X (10 mM HEPES,
pH 7.4, 140 mM KCl, 1 mM MgCl2, and 1 mM MnCl2), incubated
under bubbling N2 for 5 min at 4jC to allow thorough mixing and
maximum interface between sample and resin, and then incu-
bated for an additional 15 min without N2 bubbling.
The solution was poured into a column and left to stand for
another 15 min at 4jC. The column was eluted under bubbling
N2 at a rate of 2 ml/min, and 10 ml fractions were collected until
the absorbance at 280 nm was close to zero. Based on the en-
richment of nonraft marker proteins (CXCR4) and the absence/
reduced level of lipid raft markers (flotillin-1, SR-B1, Gqa, and
GM1), the eluent was designated as “nonraft.” ConA-adherent
fractions were then eluted under bubbling N2 with buffer Y
(buffer X plus 0.75 M a-methylmannoside) and were collected
at 4jC in 10 ml fractions at 2 ml/min until the absorbance at
280 nm reached a plateau. Based on the enrichment of lipid raft
markers (flotillin-1, Gqa, SR-B1, and GM1) and the absence/
reduced level of the nonraft marker (CXCR4), the fraction elut-
ing with buffer Y was designated as “lipid raft.” Fractions rich
in lipid raft markers and nonraft markers were pooled sepa-
rately and concentrated with Amicon Ultra-15 centrifuge filters
(Ultracel 10K; Millipore Corp., Billerica, MA) as indicated by
the manufacturer.
The method described above using affinity chromatography to
resolve nonrafts and lipid rafts from purified plasma membranes
avoided the use of detergents or high-pH carbonate buffers and
was the method of choice in the present work for the follow-
ing reasons. i) The affinity chromatography method is the only
method that simultaneously isolates lipid rafts and nonrafts from
purified plasma membranes (1, 11–14). ii) Direct comparison of
the properties of lipid rafts isolated by this affinity chromatog-
raphy method versus the classic Triton X-100 detergent method
showed that the affinity chromatography produced lipid rafts
that structurally and functionally most closely resembled those of
intact cells (13). iii) Lipid rafts isolated by the affinity chro-
matography method exhibited the least amount of nonraft and
intracellular contaminants. Mass spectrometry-based proteomics
(19) and Western blotting (13, 14) demonstrate that detergent-
resistant membranes may contain 30–60% cross-contaminating
nonraft and intracellular proteins. Lipid rafts isolated through
the use of high-pH bicarbonate buffer may also be highly impure,
as shown by MS-based proteomics demonstrating the presence of
75% cross-contaminating nonraft and intracellular proteins (19).
iv) There is increasing concern that detergent-resistant mem-
branes may not necessarily equate with lipid rafts, quantitatively
Lipid raft domains in SCP-2/SCP-x null hepatocytes 2195
reflect the proportion of plasma membrane occurring as lipid
rafts, or function as lipid rafts (reviewed in Refs. 1, 13, 20, 21).
Western blot analysis of lipid raft and nonraft fractions
To determine the relative purity of the plasma membrane
nonraft and lipid raft fractions eluted from the ConA affinity
column, aliquots of each fraction were separated by SDS-PAGE
and analyzed by Western blotting (22) to detect relative ex-
pression levels of caveolin-1, flotillin, SR-B1, SCP-2, transferrin
receptor, CXCR4, eNOS, Gqa, ABCA1, and P-gp. Briefly, 10 mg of
protein (homogenate, plasma membrane, lipid raft, and non-
raft) was loaded onto Tricine gels (12%). Gels were run on a
Mini-Protean II cell (Bio-Rad Laboratories, Hercules, CA) system
at 100 V constant voltage for ?1.5–2 h (30 mA per gel initially).
Proteins were electrophoretically transferred to nitrocellulose
membranes (Bio-Rad) by applying a 100 V constant voltage for
2 h. After transfer, the blots were blocked in 3% gelatin in TBST
(10 mM Tris-HCl, pH 8, 100 mM NaCl, and 0.05% Tween-20) for
1 h at room temperature. The blots were then washed twice with
TBST and incubated overnight at room temperature with the re-
spective polyclonal rabbit primary antibodies at dilutions of 1:250
(anti-flotillin, anti-ABCA1, anti-P-gp, and anti-SR-B1), 1:500 (anti-
SCP-2, anti-caveolin-1, anti-eNOS, and anti-CXCR4), or 1:1,000
(anti-Gqa and anti-transferrin receptor) in 1% gelatin in TBST.
The blot was then washed three times with TBST and incubated
for 2 h at room temperature with the appropriate secondary anti-
body (alkaline phosphatase conjugates of goat anti-rabbit IgG)
diluted 1:4,500 in 1% gelatin TBST.
Next, the blot was washed three times with TBST and bands of
interest were visualized by development with Sigma Fast 5-bromo-4-
chloro-3-indolyl phosphate/nitroblue tetrazolim tablets (Sigma)
according to the manufacturer’s protocol. Images of each blot were
acquired using a single-chip charge-coupled device video camera
and a computer workstation (IS-500 system; Alpha Innotech, San
Leandro, CA). Densitometric analysis of image files was then per-
formed (mean eight bit gray scale density) using NIH Image, avail-
able by anonymous FTP from zippy.nimh.nih.gov, to obtain relative
levels of the respective proteins detected in each fraction. SCP-2
levels were obtained by comparison with standard curves of known
amounts of pure SCP-2 on the same blot. After densitometric
analysis of both the standard curve and unknowns on Western
blots, image intensities in unknowns were quantitated by com-
parison with an SCP-2 standard curve within the linear range. For
those proteins for which no source of pure protein was available
(caveolin-1, flotillin, SR-B1, transferrin receptor, CXCR4, eNOS,
Gqa, ABCA1, and P-gp), relative protein levels were quantified as
described above and expressed as integrated density values.
Immunoelectron microscopy
Small segments of liver tissue from a female wild-type mouse
were fixed by immersion in alcohol-free 4% formaldehyde and
0.1% glutaraldehyde in 0.1 M Na phosphate buffer (pH 7.4) for
20 h at 4jC. The tissue segments were washed in 0.1 M Na
phosphate buffer, dehydrated in an ascending ethanol gradient
at progressively lower temperatures (23), infiltrated overnight
at 250jC with Lowicryl HM20 acrylic resin, and polymerized by
UV light. Ultrathin sections (60–80 nm) of liver were mounted
on Formvar/carbon-coated nickel grids and immunostained by
procedures recommended in the immunogold reagent product
literature (Aurion, Wageningen, The Netherlands) with several
modifications. Briefly, grids were incubated for 20 min in block-
ing solution of 1% acetylated BSA (Aurion) in 20 mM Tris-
buffered saline and 0.05% Tween-20 (TBS-Tween), pH 7.35, and
rinsed in TBS-Tween. Grids were incubated in rabbit anti-
caveolin-1 antiserum diluted 1:50 in TBS-Tween with 0.1% BSA
for 18 h at 4jC. After washing six times with TBS-Tween and 0.1%
BSA, the grids were incubated for 2 h at 24jC with goat anti-
rabbit IgG conjugated to 15 nm gold (Aurion) diluted 1:75 in
TBS-Tween and 0.1% BSA. Unbound antibodies were removed
from the sections by washing six times with TBS-Tween and 0.1%
BSA, then the grids were rinsed with deionized water and post-
stained very briefly with aqueous uranyl acetate and Reynold’s
lead citrate. Immunogold labeling patterns on cells were ex-
amined at 80 kV with a Zeiss 10c transmission EM (Carl Zeiss
Microimaging, Inc., Thornwood, NY).
Lipid extraction and analysis
Ganglioside GM1 levels were determined by a dot-blot technique
as described elsewhere (12). Lipids from homogenate, lipid raft,
and nonraft fractions were resolved into individual lipid classes as
described (12). In brief, samples were extracted with n-hexane-2-
propanol (3:2, v/v), spotted onto Silica Gel G TLC plates, and de-
veloped in petroleum ether-diethyl ether-methanol-acetic acid
(90:7:2:0.5, v/v/v/v) (24). Neutral lipid content including total
cholesterol, FFA, and cholesteryl ester was determined by the
method of Marzo et al. (25). Total phospholipids, which included
choline glycerophospholipid (PC), sphingomyelin (SM), ethanol-
amine glycerophospholipid (PE), phosphatidic acid (PA), phos-
phatidylinositol (PI), and phosphatidylserine (PS), were scraped
from the Silica Gel G TLC plates and eluted using chloroform/
methanol/HCl (100:50:0.375, v/v/v). Samples were dried under
N2 and resuspended in chloroform. Half of each sample was used
for phospholipid fatty acid mass analysis and half was applied to
Silica Gel 60 TLC plates to resolve individual phospholipids using
chloroform-methanol-water-acetic acid (150:112.5:6:10.5, v/v/v/v).
Phospholipid spots were visualized by iodine vapor and identified
by comparison with known standards (26). Individual phospho-
lipids were quantitated densitometrically as described (27) and
confirmed by phosphorus estimation (28).
Both methods yielded similar quantity and percentage dis-
tribution of phospholipid classes. In brief, quantitative analysis
was performed by analyzing spot intensity (as for proteins in
Western blotting) and compared with linear phospholipid stan-
dard curves generated with the same TLC plate to determine
phospholipid mass (27). Phospholipid identity was verified by
comparison with known phospholipid standards and by lipid
phosphorus assay (28). In several fractions, two SM bands were
separated on the TLC plate, as reported by other investigators
(29). The upper band (SM2) was differentiated from PC (next in
order of resolution from the bottom of the TLC plate) by com-
parison with known phospholipid standards, by lipid phosphorus
estimation (28), and was confirmed by GC-MS, noting the dif-
ferences in the phospholipid fatty acid composition of SM versus
PC. The SM fraction was composed of little to no PUFAs and
exhibited a prevalence of 20:0, 22:0, 24:0, and 24:1 versus the PC
fraction, with substantial levels of PUFAs, including 18:2, 20:4,
and 22:6 (29). When comparing SM2 versus SM1, the longer
chain fatty acids partitioned more into SM2, including 22:0, 24:0,
and 24:1, whereas SM1 was composed of mostly 16:0, 18:0, 18:1,
and 20:0 (29). Protein concentration was determined by the
method of Bradford (30) from the dried protein extract residue
digested overnight in 0.2 M KOH. Lipids were stored under an
atmosphere of N2 to limit oxidation, and all glassware was washed
with sulfuric acid-chromate before use.
Phospholipid fatty acid distribution
To obtain the fatty acid composition of each of the major
individual phospholipid classes (PC, SM, PS, PI, and PE/PA) in
lipid rafts and nonrafts, each phospholipid class was transester-
ified by acid to convert the phospholipid acyl chains to fatty acid
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methyl esters. Individual fatty acid methyl ester species were re-
solved according to chain length and unsaturation by GC-MS
using an RTX-2330 capillary column (0.25 mm i.d.3 30 m; Restek,
West Chester, PA) on a Thermo-Finnigan Trace DSQ single
quadruple mass spectrometer (Thermo Electron Corp., Austin,
TX) with electron impact and chemical ionization sources. In-
jector and detector temperatures were set at 240jC, with a
temperature program of 100jC for 1 min, 10jC/min to 140jC,
then 2jC/min to 220jC, hold for 1 min, then ramp 20jC/min
to 240jC. Individual peaks were identified by comparison with
known fatty acid methyl ester standards (Nu-Chek Prep) and ref-
erenced against a set concentration of 15:0 added before analysis.
Sample identity was confirmed by GC-MS using the Trace DSQ
single quadruple in chemical ionization mode.
Structure of hepatocyte plasma membrane lipid raft
and nonraft domains
Fluorescent probes (DHE, cis-parinaric acid, NBD-stearic acid,
DPH, DPH-TMA, and DPH-Pro), prepared as stock solutions
in anhydrous ethanol with 2% (w/v) butylated hydroxytoluene
added as an antioxidant, were allowed to incorporate into lipid
rafts and nonrafts. Briefly, aliquots of lipid raft or nonraft frac-
tions (35 mg of protein per 2 ml of 10 nM PIPES buffer, pH 7.4)
were incubated at 37 6 0.4jC with a small amount of fluorescent
probe (protein-fluorophore ratio 5 1,000 mg of protein to 1 mg of
fluorophore) added from a concentrated stock solution in etha-
nol. The final ethanol concentration was ,25 mM, well below
that which would perturb membrane structure, lipid distribution,
or fluidity (reviewed in Refs. 12, 13, 31), induce artifacts (sterol
self-aggregation/crystallization) in membrane fractions (32), or
disrupt protein-lipid interactions (33). Maximal probe incorpo-
ration was ensured by incubation for 30 min at 37jC. Steady-state
fluorescence polarization was acquired with a PC1 spectrofluo-
rometer in the T-format using photon-counting electronics (ISS
Instruments, Inc., Champaign, IL) as described previously (13,
31). Polarization data were corrected for residual light scatter by
converting polarization to anisotropy (r 5 2P/3P) and subtract-
ing residual fluorescence anisotropy from all measurements. To
avoid inner filter effects, the absorbance of each sample (fluo-
rescent probe 1 sample) at the wavelength of excitation for each
probe was maintained at ,0.15.
The following fluorescent lipidic probe molecules were
chosen based on their ability to preferentially report on select
aspects of membrane structure: i) DHE polarization, to probe
the relative fluidity of sterol in lipid rafts and nonrafts (13, 31,
32); ii) DPH polarization, to probe for the presence of inter-
mediate liquid-ordered phase lipids (reviewed in Ref. 34); iii) cis-
parinaric acid and NBD-stearic acid polarization, to probe the
acyl chain fluidity of naturally occurring and synthetic fatty
acids, respectively (reviewed in Ref. 12); and iv) DPH-TMA and
DPH-Pro polarization, to selectively probe the fluidity of the
hydrophobic acyl chain region of lipids in the outer (exofacial)
and inner (cytofacial) leaflets of plasma membranes, respectively,
(i.e., transbilayer fluidity gradient). The leaflet selectivity of
each of the probes (i.e., transbilayer distribution) within isolated
plasma membrane fragments was verified by leaflet-selective
quenching studies performed as reviewed in Refs. 35, 36 and
detailed in the following individually cited papers showing
that the inner and outer leaflets of isolated plasma membrane
vesicles/fragments differ in fluidity: i) leaflet-selective quenching
of DPH (nonselectively partitions into both leaflets) (37–39); ii)
studies with right side-out and inside-out plasma membranes
(38); iii) studies with the leaflet-selective DPH derivatives DPH-
TMA and DPH-Pro (39), which are anchored closer to the mem-
brane surface than DPH (40); iv) spin-label probes and purified
right side-out and inside-out oriented plasma membranes (41);
and v) model membrane studies of fluidity of outer versus inner
leaflet phospholipid mixtures (42). Based on the these previous
findings, fluorescence polarization of the leaflet-selective DPH
derivatives DPH-TMA and DPH-Pro were used to measure the
transbilayer fluidity gradient in hepatocyte plasma membrane
lipid rafts and nonrafts exactly as described earlier (13, 39).
These two plasma membrane vesicle fractions resolved by ConA
affinity chromatography are both oriented right side out (11).
Although the mechanisms whereby the DPH-TMA and DPH-Pro
translocate and distribute selectively across the membrane are
not known, it is established that zwitterionic phospholipids (PC
and SM) and anionic phospholipids (PS) are enriched in the
exofacial and cytofacial leaflets, respectively, as a result of the
action of phospholipid flippases and/or scramblases present in
the plasma membrane (43, 44). Thus, based on the similarities of
charged polar head groups, it may be postulated that DPH-TMA
(a zwitterionic polar head group) and DPH-Pro (an anionic polar
head group) are translocated by plasma membrane flippases
and/or scramblases to distribute similarly to their zwitterionic
and anionic phospholipid counterparts. Finally, in support of the
finding that leaflet-selective DPH-TMA and DPH-Pro show a
more rigid cytofacial leaflet and a more fluid exofacial leaflet
(39), studies with a nonflipping ESR probe inserted into right
side-out and inside-out oriented plasma membranes confirm the
more rigid cytofacial leaflet and more fluid exofacial leaflet (41).
Statistical analysis
All data values are expressed as means 6 SEM (n 5 3–7). To
obtain statistical differences between values, ANOVA combined
with the Newman-Keuls multiple comparisons test (GraphPad
Prism, San Diego, CA) was performed. Differences at the P, 0.05
level were considered statistically significant.
RESULTS
Generation of SCP-2/SCP-x gene-ablated mice
To generate SCP-2/SCP-x null mice, a targeting con-
struct was designed that replaced exon 16 of the SCP-2/
SCP-x gene with a neomycin cassette (Fig. 1A). This strategy
was based on the fact that the SCP-2/SCP-x gene contains
two separate promoters separately encoding the 58 kDa
SCP-x protein (composed of exons 1–16) and the 15.2 kDa
pro-SCP-2 protein (composed of exons 12–16). Both SCP-x
and pro-SCP-2 share the same C terminus (including exon
16), and both are posttranslationally processed to the
13.2 kDa SCP-2, so that ablation of exon 16 removes key
sequences, resulting in full deletion of SCP-2 and SCP-x.
The gene-targeted mice were screened by Southern blot
analysis (Fig. 1B), PCR (Fig. 1C), and Western blot analysis
(Fig. 1D). As predicted from the construct design, SCP-2
proteins (the 58 kDa SCP-x, 15.2 kDa pro-SCP-2, and
13.2 kDa SCP-2 derived from proteolytic cleavage of the
15.2 kDa SCP-2 and/or potentially from the 58 kDa SCP-x
protein) were undetectable in livers from SCP-2/SCP-x
null mice, thus confirming gene ablation.
Affinity chromatography of purified plasma membranes
isolated from primary hepatocytes
The first step to isolate lipid rafts and nonrafts from
hepatocyte plasma membranes was to purify the plasma
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membrane, as described in Materials and Methods. West-
ern blot analysis was performed to determine the presence
of select protein markers (flotillin, SR-B1, SCP-2, transfer-
rin receptor, and CXCR4) in the hepatocyte homogenate
(Fig. 2, lane 1) and in purified plasma membranes (Fig. 2,
lane 2) isolated from wild-type mice. Enrichment of flo-
tillin (Fig. 2A) and SR-B1 (Fig. 2B) was observed in the
plasma membrane fraction compared with the hepato-
cyte homogenate. SCP-2 (Fig. 2C), transferrin receptor
(Fig. 2D), and CXCR4 (Fig. 2E) were also detected in ho-
mogenates and plasma membranes but did not appear
to be enriched in the latter. Resolution of the purified
plasma membrane fraction by ConA Sepharose affinity
chromatography, as described in Materials and Methods,
yielded two fractions, a nonadherent fraction and an
adherent fraction (eluted with buffer containing the dis-
placing sugar a-methylmannoside). Enrichment of marker
proteins and lipids in the ConA nonadherent and adher-
ent fractions isolated from peripheral cell types (fibro-
blasts and MDCK cells) previously established these
fractions to be enriched in nonrafts and lipid rafts, re-
spectively (1, 12, 13).
In the present work, when the hepatocyte plasma mem-
brane fraction was passed over a ConA Sepharose affinity
column, two fractions were obtained: a nonadherent frac-
tion (67 6 5% of total protein) and an adherent fraction
(33 6 3% of total protein) (Fig. 3A). Thus, although the
nonraft fraction had nearly 2-fold more protein than the
Fig. 1. Generation of the sterol carrier protein-2 (SCP-2)/SCP-x null mouse. A: Targeted mutation of the
SCP-2 gene is indicated in the upper diagram. Exon 16 is replaced by a neomycin resistance cassette through
homologous recombination. The lower diagram shows the mutated SCP-2 gene with the KpnI sites, external
probe 1, and Neo probe indicated. B: Southern blot of KpnI-digested DNA probed with external probe 1
shows the wild-type (15 kb) and targeted (6 kb) DNA. C: PCR screening of tail DNA from SCP-2/SCP-x wild-
type (1/1) and SCP-2/SCP-x heterozygous (1/2) mice. D: Western blot analysis of liver cell homogenates
(10 mg) from SCP-2/SCP-x (2/2) null (lane 2) and wild-type (lane 3) mice probed with an affinity-purified
rabbit polyclonal antibody directed against SCP-2, which recognizes SCP-2 and SCP-x gene products. TK
indicates thymidine kinase.
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lipid raft fraction in wild-type mice, the lipid raft fraction
represented a significant component of the plasma mem-
brane. To determine whether SCP-2/SCP-x gene ablation
altered the relative proportion of plasma membrane rep-
resenting lipid rafts, protein distribution was determined
in lipid rafts and/or nonrafts isolated from purified
plasma membranes obtained from livers of SCP-2/SCP-x
gene-ablated mice (Fig. 3A). The nonadherent, nonraft
fraction represented 51 6 2% of the plasma membrane
protein (significantly less than observed with the wild-type
fraction), whereas the ConA adherent lipid raft accounted
for 49 6 2% of the plasma membrane protein (signifi-
cantly more than the wild-type fraction). In summary, bio-
chemical fractionation indicated the presence of lipid rafts
in the plasma membrane of primary hepatocytes, where
they represented a significant proportion. Furthermore,
SCP-2/SCP-x gene ablation significantly increased the size
of the lipid raft fraction by 48% (P < 0.04, n 5 6) at the
expense of the nonraft fraction.
Distribution of protein markers in ConA nonadherent and
adherent fractions
To confirm that the ConA nonadherent and adherent
fractions from hepatocyte plasma membranes indeed rep-
resented nonraft- and lipid raft-enriched fractions, Western
blotting for marker proteins was performed as described
in Materials and Methods to determine the presence of
nonraft markers [transferrin receptor (45) and CXCR4
(46)] and lipid raft markers [flotillin (12) and Gqa (47)].
Although the transferrin receptor (also known as CD71) is
an excellent protein marker for nonrafts in endothelial
cells as well as many different cell lines and primary cells
(45, 48, 49), in this work transferrin was not detectable in
the nonadherent fraction isolated from primary mouse
hepatocytes (data not shown). However, when the non-
adherent fraction was tested for another nonraft protein
marker, CXCR4, levels were 10.8-fold greater in the ConA
nonadherent fraction compared with the adherent frac-
tion (Fig. 3D). To distinguish whether the nonadherent
fraction was deficient in lipid raft protein markers, West-
ern blotting of known lipid raft protein markers (flotillin
and Gqa) was also performed. The nonadherent fraction
was essentially devoid of flotillin (Fig. 3B, hatched bar)
and Gqa (Fig. 3C, hatched bar) compared with either the
cell homogenate (Fig. 3, open bars) or the ConA adherent
fraction (Fig. 3, closed bars). In contrast, Western blot
analysis of the ConA adherent fraction showed .9-fold en-
richment in flotillin (Fig. 3B) and 14-fold enrichment in
Gqa (Fig. 3C) compared with the nonadherent fraction.
In SCP-2/SCP-x gene-ablated mice, with the exception of
SCP-2 being absent, the pattern of protein markers for
lipid rafts was similar to that in wild-type mice (i.e., en-
richment of flotillin and Gqa in lipid rafts and enrichment
of CXCR4 in nonrafts). In summary, the Western blotting
of protein markers confirmed that the ConA nonadherent
and adherent fractions were enriched in nonrafts and lipid
rafts, respectively, and expression of SCP-2/SCP-x signif-
icantly altered the relative proportion of lipid rafts versus
nonrafts in the plasma membrane of primary hepatocytes.
Distribution of lipid markers in the ConA nonadherent
and adherent fractions
To further confirm that the ConA nonadherent and ad-
herent fractions from hepatocyte plasma membranes rep-
resented nonraft- and lipid raft-enriched fractions, lipid
analyses for marker lipids were performed as described in
Materials and Methods. Lipid rafts from peripheral cells
are known to be enriched in total lipid, cholesterol, phos-
pholipid, and sphingolipids (GM1 and SM) (reviewed in
Ref. 13). In this work, the adherent fraction was lipid-rich, as
shown by the .3-fold higher total lipid/protein compared
with the ConA nonadherent fraction (Fig. 4A). Examina-
tion of individual lipid classes from lipid rafts of wild-type
mice revealed that the adherent fraction had several-fold
more ganglioside GM1 (Fig. 4B), SM (Fig. 4C), total choles-
terol (Fig. 4D), and total phospholipids (Fig. 4E) compared
with the ConA nonadherent fraction or the cell homoge-
nate. The molar ratio of cholesterol-phospholipid (C/P)
was .2-fold higher in the adherent fraction compared with
the nonadherent fraction (Fig. 4F).
To determine whether the difference in total phospho-
lipids in the nonraft and lipid raft fractions was attribut-
able to preferential distribution of select phospholipid
classes, the mass (nmol/mg protein) and distribution (%)
of the individual phospholipid classes, including PC, PS,
PI, and PE/PA, were analyzed as described in Materials
and Methods. In the cell homogenate of wild-type hepato-
cytes (Fig. 5A, open bars), the relative distribution of in-
dividual phospholipid classes was in the order PC.. PE .
PS and PI. When plasma membranes were fractionated
into lipid rafts and nonrafts, the masses (nmol/mg pro-
tein) of all of the phospholipid classes were substantially
lower, but not equally so, in the lipid raft compared with
the nonraft fractions (Fig. 5B): the content of PC, PS, PI,
and PE in lipid rafts of wild-type hepatocytes was 1.7-, 5.4-,
Fig. 2. Western blot analysis of homogenate and plasma membrane
proteins in hepatocytes derived from male wild-type SCP-2/SCP-x
mice. Levels of flotillin (A) scavenger receptor class B type I (SR-B1)
(B), SCP-2 (C), transferrin receptor (D), and CXCR4 (E) were de-
termined by Western blot analysis (see Materials and Methods) in
homogenate (lane 1) and plasma membranes (PM; lane 2).
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3.7-, and 1.9-fold higher than in the nonraft fraction (P ,
0.05, n 5 3–6). When expressed as the relative prevalence
(%) of polar lipids, individual phospholipid classes were
in the order PC (39 6 2%) . SM (21 6 2%) and PE (21 6
2%) . PI (10 6 1%) and PS (10 6 1%) in lipid rafts
isolated from wild-type hepatocytes (Fig. 5C). In nonrafts
from wild-type hepatocytes, the relative percentage of
PC was significantly higher than in lipid rafts, whereas
the nonraft percentage of PI and PS decreased by .50%
(Fig. 5C). Thus, in wild-type hepatoctyes, the ratio of an-
ionic to neutral zwitterionic phospholipids [i.e., (PS 1
PI)/(PC 1 PE 1 SM)] was .2-fold higher in lipid rafts
than nonrafts (Fig. 5D).
To determine whether SCP-2/SCP-x gene ablation
altered the lipid composition of hepatocytes, lipids were
extracted, resolved by TLC, and quantitated as described
in Materials and Methods. Although SCP-2/SCP-x gene
ablation did not alter the total mass of lipid (Fig. 4A)
or total phospholipid (Fig. 4E) in cell homogenate, the
masses of GM1 (Fig. 4B), PS (Fig. 5A), and PI (Fig. 5A) in
cell homogenate were increased by 1.4-, 3.1-, and 2.4-fold,
respectively. To determine whether the latter enrichments
were selectively reflected in lipid rafts versus nonrafts,
the individual lipid classes of these fractions from SCP-2/
SCP-x null mice were examined. Although SCP-2/SCP-x
gene ablation did not alter the mass of total cholesterol in
lipid rafts or nonrafts (Fig. 4D), the total mass of phos-
pholipids was significantly increased by 1.2-fold in lipid
rafts and decreased by 50% in nonrafts (Fig. 4E). Con-
sequently, there was no significant difference in the C/P
ratio between these fractions isolated from plasma mem-
branes of hepatocytes from SCP-2/SCP-x mice (Fig. 4F).
SCP-2/SCP-x gene ablation also significantly decreased
the level of the sphingolipid GM1 by 27% (Fig. 4B) and PE
by 20% (Fig. 5B) in lipid rafts but not nonrafts. Concomi-
tantly, SM (Fig. 4C), PC (Fig. 5B), and PI (Fig. 5B) in-
creased by 2.4-, 1.4-, and 1.7-fold, respectively, in lipid rafts.
With regard to the other individual polar lipid classes, lack
of SCP-2/SCP-x did not alter the lipid raft mass (nmol/mg
protein) of PS (Fig. 5B).
Fig. 3. Distribution of plasma membrane (PM) protein markers in hepatocyte plasma membrane nonraft
and lipid raft fractions. A: Total protein distribution in lipid rafts (closed bar) and nonrafts (hatched bar)
isolated from wild-type and SCP-2/SCP-x null mice. B–D: Quantitative analysis of protein expression was
performed on flotillin (B), Gqa (C), and CXCR4 (D) in homogenate (open bars), nonraft (hatched bars),
and lipid raft (closed bars) fractions derived from SCP-2/SCP-x null and wild-type hepatocytes. E–G:
Representative Western blots performed on i) SCP-2/SCP-x wild-type hepatocyte homogenate (lane 1),
nonraft (lane 2), and lipid raft (lane 3) fractions and ii) SCP-2/SCP-x null hepatocyte homogenate (lane 4),
nonraft (lane 5), and lipid raft (lane 6) fractions to determine expression levels of flotillin (E), Gqa (F), and
CXCR4 (G). Values in A–D represent means 6 SEM (n 5 3–6). * P , 0.02 for wild-type (WT) homogenates
versus SCP-2/SCP-x null (KO) homogenates; ** P , 0.05 for homogenate versus nonraft or lipid raft within
each group (WT or KO); @P , 0.01 for nonraft versus lipid raft within each group (WT or KO); 1 P , 0.05
for WT lipid raft versus KO lipid raft; ^ P , 0.04 for WT nonraft versus KO nonraft.
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When phospholipid composition was expressed as a
percentage, SCP-2/SCP-x gene ablation increased the per-
centage of SM in lipid rafts while decreasing the per-
centage of PE versus that in lipid rafts from wild-type
hepatocytes (Fig. 5C). In nonraft fractions, lack of SCP-2/
SCP-x expression did not significantly affect either the
mass (Fig. 5B) or the percentage composition (Fig. 5C) of
any of the phospholipid classes examined, with the ex-
ception of PI, whose percentage (Fig. 5C) but not mass
(Fig. 5B) was increased somewhat. Finally, the overall ratio
of anionic to neutral zwitterionic phospholipids was not
changed in SCP-2/SCP-x null lipid rafts but increased by
2.4-fold in nonrafts (Fig. 5D) compared with the corre-
sponding fractions from wild-type hepatocytes. In sum-
mary, the lipid marker distribution confirmed that the
ConA nonadherent and adherent fractions were enriched
in nonrafts and lipid rafts, respectively. In wild-type
hepatocytes, lipid rafts were enriched in total lipids, total
cholesterol, total phospholipids, and cholesterol-to-phos-
pholipid ratio, as well as by mass in polar lipid classes
(GM1, PC, SM, PE, PS, and PI), compared with nonrafts.
SCP-2/SCP-x gene ablation significantly increased the
total lipid content, total phospholipid, and select phos-
pholipid classes (SM, PC, and PI) in lipid rafts. Further-
more, SCP-2 gene ablation abolished the difference in the
C/P ratio in lipid rafts versus nonrafts by increasing the
content of total phospholipid in lipid rafts and decreasing
the content of total phospholipid in nonrafts, without
altering cholesterol mass.
Select distribution of proteins involved in HDL-mediated
cholesterol uptake/efflux in lipid rafts
To determine whether key proteins involved in RCT
(ABCA1, P-gp, SR-B1, SCP-2, and caveolin-1) were com-
partmentalized in lipid rafts, Western blotting for the
respective proteins was performed. Compared with the
nonraft fraction of plasma membranes from hepatocytes,
the lipid raft fraction was highly enriched by .100-fold in
SCP-2 (Fig. 6A, E), 6.6-fold in ABCA1 (Fig. 6B, F), 7.4-fold
in P-gp (Fig. 6C, G), and 11-fold in SR-B1 (Fig. 6D, H). The
presence of caveolin-1 was not detected in lipid rafts or
nonrafts (Fig. 7A, lanes 2 and 3, respectively). Indeed,
although Western blotting detected caveolin-1 in liver
homogenates (Fig. 7A, lane 1), the concomitant presence
of high levels of eNOS therein (Fig. 7B, lane 2) suggested
that caveolin-1 may reside in nonhepatic cells (endo-
thelial, stellate, and Kupffer cells) rather than in hepa-
toctyes. Consistent with this possibility, eNOS (Fig. 7B,
lane 3), the transferrin receptor [protein marker present
in nonrafts of other cell types (45, 48, 49)], in addition to
caveolin-1 (Fig. 7, lanes 2, 3) were absent in lipid raft and
nonraft fractions isolated from hepatocyte cells. Because
Fig. 4. Distribution of lipid markers in hepatocyte nonraft and lipid raft fractions. Total lipids (A),
ganglioside GM1 (B), sphingomyelin (C), total cholesterol (D), total phospholipids (E), and the cholesterol-
phospholipid (C/P) ratio (F) were determined in homogenates (open bars), nonrafts (hatched bars), and
lipid rafts (closed bars) isolated from SCP-2/SCP-x null and wild-type hepatocytes. Values represent
means 6 SEM (n 5 3–9). * P , 0.03 for wild-type (WT) homogenates versus SCP-2/SCP-x null (KO) ho-
mogenates; ** P , 0.04 for homogenate versus nonraft or lipid raft within each group (WT or KO); @ P ,
0.03 for nonraft versus lipid raft within each group (WT or KO); 1 P, 0.04 for WT lipid raft versus KO lipid
raft; ^ P , 0.02 for WT nonraft versus KO nonraft.
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liver contains not only hepatocytes but also a variety
of other cells (endothelial, stellate, and Kupffer cells),
the latter being enriched in caveolin-1 (50, 51), antigenic
sites of caveolin-1 were also localized on thin sections of
liver with 15 nm gold particles using immunogold elec-
tron microscopy. Multiple sites of caveolin-1 in endothelial
cells (Fig. 7C, arrowheads) and other nonparenchymal
cell types (data not shown) were observed. In contrast,
hepatocytes (Fig. 7D) did not show staining for caveolin-1
above random background levels. These results were
consistent with the absence of caveolin-1 from hepato-
cytes both in mouse hepatocyte primary cell cultures and
in vivo.
Distribution of lipids associated with HDL-mediated
cholesterol transfer in lipid rafts
In peripheral cells, selective transfer of cholesterol and
cholesteryl ester associated with HDL (which binds SR-B1)
is mediated through lipid rafts rich in ABCA1, P-gp, and
SR-B1 (reviewed in Ref. 13). Because hepatocyte lipid rafts
were enriched in ABCA1, P-gp, SR-B1, and SCP-2, the
possibility that not only unesterified cholesterol but also
small amounts of cholesteryl ester might be detectable in
lipid rafts was examined. Compared with the nonrafts,
lipid rafts had 4.9-fold more unesterified cholesterol (see
supplementary Fig. I) but similar small levels of cholesteryl
ester (see supplementary Fig. IB). In addition, lipid rafts
Fig. 5. Distribution of individual phospholipid classes in hepatocyte nonraft and lipid raft fractions.
A: Levels of individual phospholipids in homogenates isolated from SCP-2/SCP-x null (closed bars) and
SCP-2/SCP-x wild-type (open bars) hepatocytes were determined as described in Materials and Methods.
B: Levels of individual phospholipids in SCP-2/SCP-x wild-type nonrafts (open bars) and lipid rafts (hatched
bars) and in SCP-2/SCP-x null nonrafts (shaded bars) and lipid rafts (closed bars). C: Percentage com-
position of individual phospholipids in SCP-2/SCP-x wild-type nonrafts (open bars) and lipid rafts (hatched
bars) and in SCP-2/SCP-x null nonrafts (shaded bars) and lipid rafts (closed bars). D: Ratio of anionic
to neutral/zwitterionic (A/N) phospholipids in each fraction. PC, choline glycerophospholipid; PE, eth-
anolamine glycerophospholipid; PI, phosphatidylinositol; PS, phosphatidylserine. Values represent
means 6 SEM (n 5 3–6). * P , 0.03 for wild-type (WT) homogenates versus SCP-2/SCP-x (KO) ho-
mogenates; ** P , 0.02 compared with WT nonraft fraction within each phospholipid; @ P , 0.001 com-
pared with KO nonraft fraction within each phospholipid; 1 P , 0.05 compared with WT lipid raft within
each phospholipid.
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had 3.5-fold more FFA (see supplementary Fig. IC) com-
pared with the nonraft fraction, consistent with the enrich-
ment of fatty acid transport proteins in lipid rafts (52).
Distribution of phospholipid polyunsaturated fatty acids
that regulate the distribution of proteins to lipid rafts
Select phospholipid classes were next examined. SM of
both lipid rafts and nonrafts was relatively enriched in
saturated (16:0, 18:0, 20:0, 22:0, and 24:0) and monoun-
saturated (16:1, 18:1, 20:1, 22:1, and 24:1) fatty acids while
being relatively poor in polyunsaturated fatty acids (see
supplementary Table I) compared with other phospho-
lipid classes (see supplementary Tables II–IV). For more
ready comparison, the individual groups of saturated
(Sat), unsaturated (Unsat), monounsaturated, and poly-
unsaturated fatty acids were summed and the ratios of Sat/
Unsat and MUFA/Sat and the double bond index (DBI)
were calculated and collated in Table 1. Thus, the DBI
(defined as the summation of the mole fraction times
the number of double bonds for each fatty acid) was 2- to
5-fold lower in SM (Table 1) than in other phospholipid
classes (Tables 2–4). In SM from wild-type hepatoctyes,
the Sat/Unsat ratio was significantly higher than in non-
rafts (Table 1). SCP-2/SCP-x gene ablation abolished
this difference (Table 1). Esterified fatty acids detected
in the lipid raft PS class from wild-type hepatoctyes
also differed significantly from nonrafts (see supplemen-
tary Table II). In wild-type hepatocyte lipid rafts, the
PUFAs were 2-fold lower, giving rise to a higher Sat/
Unsat ratio and a lower DBI compared with the nonraft
fraction (Table 2). SCP-2/SCP-x gene ablation increased
PUFA and DBI while decreasing the Sat/Unsat ratio in
lipid rafts compared with lipid rafts from wild-type hepa-
tocytes (Table 2). Concomitantly, SCP-2/SCP-x gene
ablation increased MUFA and the MUFA/Sat ratio in
nonrafts compared with nonrafts from wild-type hepa-
tocytes (Table 2). Lastly, SCP-2/SCP-x gene ablation did
not significantly alter any of the fatty acid parameters
Fig. 6. Expression of proteins involved in HDL-cholesterol trafficking in hepatocyte nonraft and lipid
raft fractions. A–D: Quantitative analysis was performed on levels of SCP-2 (A), ABCA1 (B), P-glycoprotein
(P-gp) (C), and SR-B1 (D) in homogenate (open bars), nonraft (hatched bars), and lipid raft (closed bars)
fractions derived from SCP-2/SCP-x null and wild-type hepatocytes. E–H: Western blot analysis using affinity-
purified antibodies developed against SCP-2 (E), ABCA1 (F), P-gp (G), and SR-B1 (H) was performed on the
following samples: i) SCP-2/SCP-x wild-type hepatocyte homogenate (lane 1), nonraft (lane 2), and lipid
raft (lane 3) fractions and ii) SCP-2/SCP-x null hepatocyte homogenate (lane 4), nonraft (lane 5), and lipid
raft (lane 6) fractions. Values represent means 6 SEM (n 5 3–6). * P, 0.05 for wild-type (WT) homogenates
versus SCP-2/SCP-x (KO) homogenates; ** P, 0.03 for homogenate versus nonraft or lipid raft within each
group (WT or KO); @ P , 0.01 for nonraft versus lipid raft within each group (WT or KO).
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in raft versus nonraft fractions from SCP-2/SCP-x gene-
ablated hepatocytes (Table 2).
With regard to fatty acids esterified to PC, lipid rafts
from wild-type hepatoctyes also differed significantly from
nonrafts (see supplementary Table III). In wild-type hepa-
tocytes, the lipid raft fraction PUFAs were 1.8-fold lower,
giving rise to higher Sat/Unsat ratio and lower DBI values
versus the nonraft fraction (Table 3). SCP-2/SCP-x gene
ablation had no effect on fatty acid parameters in lipid
rafts compared with lipid rafts from wild-type hepatocytes
(Table 3). Likewise, SCP-2/SCP-x gene ablation had no
effect on fatty acid parameters in nonrafts compared with
nonrafts from wild-type hepatocytes (Table 3). However,
SCP-2/SCP-x gene ablation significantly increased the
Sat/Unsat ratio by 1.5-fold in lipid rafts compared with
nonrafts from SCP-2/SCP-x gene-ablated hepatocytes
(Table 3).
For PI, the esterified fatty acids in lipid rafts from wild-
type hepatoctyes also differed significantly from nonrafts
(see supplementary Table IV). As shown in Table 4, the
wild-type lipid raft fraction had lower MUFA, MUFA/Sat
ratio, and DBI values, whereas the Sat/Unsat ratio was
higher compared with the nonraft fraction. SCP-2/SCP-x
gene ablation did not alter fatty acid parameters in lipid
rafts compared with lipid rafts from wild-type hepatocytes
(Table 4). Likewise, SCP-2/SCP-x gene ablation did not
alter these parameters in nonrafts compared with nonrafts
from wild-type hepatocytes (Table 4). However, lipid rafts
TABLE 1. Effect of SCP-2/SCP-x gene ablation on sphingomyelin
fatty acid group percentage composition in plasma membrane
nonraft and lipid raft fractions
Nonraft Raft
Fatty Acid Group Wild Type Knockout Wild Type Knockout
Saturated 54 6 9 56 6 10 63 6 6 62 6 4
Unsaturated 46 6 4 44 6 10 38 6 4 37 6 3
MUFA 39 6 4 39 6 10 32 6 4 34 6 4
PUFA 6.8 6 0.7 5.1 6 0.6 5.4 6 0.4 4.9 6 0.3
Saturated/unsaturated 1.1 6 0.1 1.3 6 0.3 1.6 6 0.2a 1.6 6 0.1
MUFA/saturated 0.7 6 0.1 0.7 6 0.2 0.52 6 0.07 0.54 6 0.06
DBI 0.3 6 0.1 0.2 6 0.1 0.3 6 0.1 0.4 6 0.1
DBI, double bond index; SCP-2, sterol carrier protein-2. Values
represent means 6 SEM (n 5 3–6). See supplementary Table I for the
percentage composition of individual sphingomyelin fatty acids.
a Significant difference compared with the plasma membrane non-
raft fraction isolated from SCP-2/SCP-x wild-type hepatocytes (P,0.05).
TABLE 2. Effect of SCP-2/SCP-x gene ablation on phosphatidylserine
fatty acid group percentage composition in plasma membrane
nonraft and lipid raft fractions
Nonraft Raft
Fatty Acid Group Wild Type Knockout Wild Type Knockout
Saturated 53 6 7 44 6 5 65 6 10 51 6 9
Unsaturated 47 6 5 56 6 5 35 6 6 49 6 6
MUFA 16 6 3 30 6 3a 20 6 4 23 6 5
PUFA 32 6 4 27 6 3 15 6 3a 27 6 4b
Saturated/
unsaturated
1.1 6 0.1 0.78 6 0.09 1.9 6 0.3a 1.0 6 0.2b
MUFA/saturated 0.31 6 0.04 0.68 6 0.09a 0.31 6 0.07 0.45 6 0.09
DBI 1.2 6 0.1 0.9 6 0.1 0.5 6 0.1a 1.0 6 0.1b
Values represent means 6 SEM (n 5 3–6). See supplementary
Table II for the percentage composition of individual phosphatidylse-
rine fatty acids.
a Significant difference compared with the plasma membrane non-
raft fraction isolated from SCP-2/SCP-x wild-type hepatocytes (P,0.03).
b Significant difference compared with the plasma membrane lipid
raft fraction isolated from SCP-2/SCP-x wild-type hepatocytes (P,0.05).
TABLE 3. Effect of SCP-2/SCP-x gene ablation on
phosphatidylcholine fatty acid group percentage composition in
plasma membrane nonraft and lipid raft fractions
Nonraft Raft
Fatty Acid Group Wild Type Knockout Wild Type Knockout
Saturated 50 6 5 49 6 7 62 6 8 61 6 5
Unsaturated 50 6 4 51 6 6 39 6 4 40 6 4
MUFA 24 6 2 31 6 5 24 6 4 24 6 3
PUFA 27 6 3 19 6 3 15 6 2a 16 6 1
Saturated/
unsaturated
1.0 6 0.1 1.0 6 0.1 1.6 6 0.2a 1.5 6 0.1b
MUFA/saturated 0.48 6 0.05 0.6 6 0.1 0.38 6 0.07 0.39 6 0.05
DBI 1.0 6 0.1 0.7 6 0.1 0.59 6 0.05a 0.70 6 0.05
Values represent means 6 SEM (n 5 3–6). See supplementary
Table III for the percentage composition of individual phosphatidyl-
choline fatty acids.
a Significant difference compared with the plasma membrane non-
raft fraction isolated from SCP-2/SCP-x wild-type hepatocytes (P,0.02).
b Significant difference compared with the plasma membrane non-
raft fraction isolated from SCP-2/SCP-x null hepatocytes (P, 0.02).
Fig. 7. Distribution of caveolin-1 in hepatocyte plasma membrane
lipid rafts (Western blot analysis) and in mouse liver (immunogold
electron microscopy). A: Caveolin-1 expression levels in liver
homogenate (lane 1), hepatocyte nonraft (lane 2), and hepatocyte
lipid raft (lane 3) fractions. B: Expression levels of endothelial
nitric oxide synthase (eNOS) in endothelial cells (lane 1; 10 mg),
liver homogenate (lane 2; 2 mg), and hepatocyte homogenate
(lane 3; 10 mg) determined as described in Materials and Methods.
C, D: Antigenic sites of caveolin-1 were immunolabeled with 15 nm
gold particles on thin sections of the endothelium (C) and
hepatocytes (D). Although numerous sites were immunolabeled
for caveolin-1 in endothelial cells, as indicated by arrowheads, only
background levels of gold binding to caveolin-1 were observed in
hepatocytes. Bar 5 1.0 mm.
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from SCP-2/SCP-x gene-ablated hepatocytes exhibited
increased saturated fatty acids and Sat/Unsat ratio con-
comitant with decreased unsaturated fatty acids, MUFA,
PUFA, and MUFA/Sat ratio compared with nonrafts from
SCP-2/SCP-x gene-ablated hepatocytes (Table 4).
Esterified fatty acids detected in the lipid raft PE class
from wild-type hepatoctyes also differed significantly from
nonrafts (see supplementary Table V). As summarized in
Table 5, in wild-type hepatocytes compared with the non-
raft fraction, the lipid raft fraction had higher saturated
fatty acids and Sat/Unsat ratio but lower unsaturated fatty
acids, PUFA, MUFA, and DBI. SCP-2/SCP-x gene ablation
had no effect on fatty acid parameters in lipid rafts com-
pared with lipid rafts from wild-type hepatocytes (Table 5).
Likewise, SCP-2/SCP-x gene ablation had no effect on
these parameters in nonrafts compared with nonrafts
from wild-type hepatocytes (Table 5). However, lipid rafts
from SCP-2/SCP-x gene-ablated hepatocytes exhibited in-
creased saturated fatty acids and Sat/Unsat ratio concom-
itant with decreased unsaturated fatty acids, MUFA, and
DBI compared with nonrafts from SCP-2/SCP-x gene-
ablated hepatocytes (Table 5). Thus, phospholipids in
lipid rafts from wild-type hepatocytes had a higher ratio of
saturated to unsaturated fatty acids versus that in nonrafts.
SCP-2/SCP-x gene ablation significantly increased the
Sat/Unsat ratio in PE, did not change this ratio in SM, PC,
or PI, and decreased this ratio in PS from lipid rafts com-
pared with lipid rafts from wild-type hepatocytes.
Fluorescence polarization of DHE in lipid raft and
nonraft microdomains
The structural properties of the sterol microenviron-
ment were probed by measuring the fluorescence polar-
ization of DHE (see Materials and Methods). Polarization
of DHE, when incorporated into rafts and nonrafts at low
amounts to avoid self-quenching as described (12, 13), was
significantly higher in lipid rafts compared with nonrafts
isolated from wild-type mice (Table 6). SCP-2/SCP-x gene
ablation had no effect on DHE polarization in lipid raft
and nonraft domains (Table 6). Thus, fluorescent sterol
sensed a more ordered (higher dehydroergosterol polar-
ization) microenvironment in lipid rafts versus nonrafts,
but SCP-2/SCP-x gene ablation had no effect on the order
of the sterol environment.
Fluorescence polarization of DPH in lipid raft and
nonraft microdomains
DPH is a probe molecule that detects the intermediate
liquid-ordered phase present in model membranes (re-
viewed in Refs. 1, 34) and biological membranes (reviewed
in Refs. 1, 13, 31) rich in sphingolipid, cholesterol, and
saturated acyl chains (i.e., lipid rafts). DPH fluorescence
polarization in lipid rafts, 0.3416 6 0046 (Table 6), was in
the same range as that reported previously in lipid rafts
from peripheral cells (reviewed in Refs. 1, 13, 31) or model
membranes (reviewed in Refs. 1, 34) as being consis-
tent with the presence of an intermediate liquid-ordered
phase. In contrast, DPH polarization in nonrafts was sig-
nificantly lower than in lipid rafts (Table 6), not in the
range consistent with the presence of the intermediate
liquid-ordered phase. SCP-2/SCP-x gene ablation signifi-
cantly increased DPH fluorescence polarization in lipid
rafts but not in nonrafts (Table 6), suggesting that SCP-2
selectively increased the intermediate liquid-ordered phase
in lipid rafts.
Fluorescence polarization of cis-parinaric acid and
NBD-stearic acid to probe fatty acyl chain structure
in lipid rafts and nonrafts
Long (i.e., 18 carbon) straight-chain fatty acids such as
the synthetic NBD-stearic acid and the naturally occurring
kinked-chain cis-parinaric acid probe the acyl chain micro-
environment of membrane lipid rafts and nonrafts (1, 13,
31). Fluorescence polarization of NBD-stearic acid and cis-
parinaric acid were both higher in lipid rafts than in non-
rafts (Table 6). SCP-2/SCP-x gene ablation significantly
increased the fluorescence polarization of both NBD-
stearic acid and cis-parinaric acid in lipid rafts but not in
nonrafts (Table 6). Thus, the acyl chain microenviron-
TABLE 5. Effect of SCP-2/SCP-x gene ablation on
phosphatidylethanolamine fatty acid group percentage composition
in plasma membrane nonraft and lipid raft fractions
Nonraft Raft
Fatty Acid Group Wild Type Knockout Wild Type Knockout
Saturated 42 6 2 45 6 3 54 6 2a 61 6 6b
Unsaturated 58 6 3 55 6 3 46 6 2a 39 6 3b
MUFA 24 6 1 25 6 2 21 6 1 19 6 2
PUFA 34 6 3 29 6 2 25 6 1a 20 6 2
Saturated/
unsaturated
0.72 6 0.04 0.83 6 0.06 1.18 6 0.06a 1.6 6 0.2b
MUFA/saturated 0.57 6 0.03 0.56 6 0.04 0.39 6 0.03a 0.30 6 0.04b
DBI 1.3 6 0.1 1.1 6 0.1 0.9 6 0.1a 0.8 6 0.1
Values represent means 6 SEM (n 5 3–6). See supplementary
Table V for the percentage composition of individual phosphatidyl-
ethanolamine fatty acids.
a Significant difference compared with the plasma membrane non-
raft fraction isolated from SCP-2/SCP-x wild-type hepatocytes (P, 0.05).
b Significant difference compared with the plasma membrane non-
raft fraction isolated from SCP-2/SCP-x null hepatocytes (P , 0.05).
TABLE 4. Effect of SCP-2/SCP-x gene ablation on
phosphatidylinositol fatty acid group percentage composition in
plasma membrane nonraft and lipid raft fractions
Nonraft Raft
Fatty Acid Group Wild Type Knockout Wild Type Knockout
Saturated 45 6 3 44 6 3 61 6 12 63 6 5a
Unsaturated 55 6 4 56 6 3 39 6 6 37 6 3a
MUFA 27 6 3 27 6 2 17 6 3b 19 6 2a
PUFA 29 6 3 29 6 3 22 6 4 18 6 2a
Saturated/
unsaturated
0.81 6 0.06 0.78 6 0.05 1.6 6 0.3b 1.7 6 0.1a
MUFA/saturated 0.59 6 0.06 0.62 6 0.04 0.27 6 0.06b 0.30 6 0.04a
DBI 1.1 6 0.1 1.0 6 0.1 0.80 6 0.05b 0.7 6 0.1
Values represent means 6 SEM (n 5 3–6). See supplementary
Table IV for the percentage composition of individual phosphatidyl-
inositol fatty acids.
a Significant difference compared with the plasma membrane non-
raft fraction isolated from SCP-2/SCP-x null hepatocytes (P , 0.01).
b Significant difference compared with the plasma membrane non-
raft fraction isolated from SCP-2/SCP-x wild-type hepatocytes (P, 0.04).
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ments sensed by NBD-stearic acid and cis-parinaric acid
were significantly more rigid (i.e., higher polarization) in
lipid rafts than in nonraft microdomains. SCP-2/SCP-x
gene ablation significantly rigidified the lipid raft micro-
environments, as indicated by increased polarization of
these probes.
Fluorescence polarization of leaflet-selective probes
(DPH-TMA and DPH-Pro) in lipid rafts and nonrafts
Fluorescence polarization of DPH-TMA was signifi-
cantly lower than that of the inner leaflet-selective probe
DPH-Pro in both lipid rafts and nonrafts (Table 6). Po-
larization of the outer leaflet-selective probe DPH-TMA
was significantly higher in lipid rafts than in nonrafts
(Table 6). SCP-2/SCP-x gene ablation increased the
polarization of DPH-TMA in lipid rafts as well as nonrafts
(Table 6). In contrast, SCP-2/SCP-x gene ablation de-
creased the polarization of DPH-Pro in lipid rafts as well as
nonrafts (Table 6). Thus, these data showed that the inner
leaflet of lipid rafts and nonrafts was significantly more
ordered (higher polarization) than was the outer leaflet.
SCP-2/SCP-x gene ablation increased the polarization of
the outer leaflet-selective probe TMA-DPH but decreased
that of the inner leaflet-selective probe DPH-Pro in both
membrane fractions, such that the ratio of DPH-TMA to
DPH-Pro polarization was increased from 0.80 to 1.00 in
lipid rafts and from 0.87 to 1.04 in nonrafts. Thus, by in-
creasing the order (DPH-TMA polarization) in the outer
leaflet while concomitantly decreasing the order (DPH-
Pro) in the inner leaflet, SCP-2/SCP-x gene ablation effec-
tively abolished the normal transbilayer fluidity difference
in both rafts and nonrafts.
DISCUSSION
Although liver hepatocytes account for the majority of
net cholesterol loss from the body, molecular details of
RCT through the hepatocyte plasma membrane are not
completely understood. Although plasma membrane
microdomains (termed lipid rafts) compartmentalize the
proteins/receptors involved in cholesterol efflux from pe-
ripheral cells, little is known about the existence and pu-
tative role of lipid rafts in liver hepatocytes. The data
presented here contributed significant new findings.
First, lipid rafts exist in hepatocyte plasma membranes,
representing 33% of total plasma membrane protein, coun-
tering the common misconception that has equated the
almost negligible levels of caveolin-1 in liver with a paucity
of raft domains. It should be noted that basically similar
amounts of lipid rafts are isolated by affinity chroma-
tography from purified plasma membranes of peripheral-
type cells such as fibroblasts (12).
Second, key protein components of RCT, including
SR-B1, ABCA1, and P-gp, were highly enriched in hepa-
tocyte lipid raft domains, but caveolin-1 was not detected
in purified lipid rafts or nonrafts. Thus, lipid rafts from
hepatocyte plasma membranes differed significantly from
those of peripheral cells. Because caveolin-1 correlates
with enhanced cholesterol efflux and the inhibition of
HDL-cholesteryl ester uptake from peripheral cells (re-
viewed in Ref. 1), lack of caveolin-1 in hepatocytes suggests
that hepatocytes are thereby optimally positioned to fa-
cilitate HDL-cholesterol/cholesteryl ester uptake rather
than efflux. For example, model membrane studies show
that both spontaneous and SCP-2-mediated cholesterol
transfer is slower from more rigid compared with fluid
membranes (reviewed in Ref. 53). Because lipid rafts are
more rigid than nonrafts, it might be expected that sterol
transfer would be faster from nonrafts than from rafts.
Based on these and other considerations, it has been pos-
tulated that the majority of exported cholesterol is not raft-
associated (reviewed in Ref. 54). On the contrary, in vitro
studies show that both spontaneous and SCP-2-mediated
cholesterol transfer are nearly 1 order of magnitude faster
from lipid rafts (enriched in RCT proteins such as SR-B1
and caveolin-1) than nonrafts isolated from plasma mem-
branes of cultured liver cell fibroblasts (12). Lipid rafts
from cultured primary hepatocytes are also enriched in
RCT proteins such as SR-B1, ABCA1, and P-gp, which are
known to confer enhanced dynamics to cholesterol be-
cause: i) SR-B1 (55) and caveolin-1 (56) directly bind
TABLE 6. Fluorescence polarization of lipidic probes in lipid rafts and nonrafts isolated from primary cultured hepatocytes
Nonraft Lipid Raft
Fluorescence Probe Wild Type Knockout Wild Type Knockout
Sterol Structure
Dehydroergosterol 0.3156 6 0.0064 0.3177 6 0.0069 0.3522 6 0.0052a 0.3605 6 0.0086a
Intermediate Liquid-Ordered Phase
1,6-Diphenyl-1,3,5-hexatriene 0.3335 6 0.0062 0.3267 6 0.0037 0.3416 6 0.0046a,b 0.3644 6 0.0045a
Acyl Chain Structure
9Z,11E,13E,15Z-Octatetradecanoic acid 0.3247 6 0.0046 0.3241 6 0.0032 0.3319 6 0.0041b 0.3629 6 0.0028a
12-(N-Methyl)-N-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-
octadecanoic acid
0.2545 6 0.0067c 0.2912 6 0.0036 0.2771 6 0.0042a,b 0.3106 6 0.0047a
Transbilayer Structure
1,6-Diphyenyl-1,3,5-hexatrienyl-trimethylammonium 0.2865 6 0.0032c 0.3284 6 0.0082 0.3139 6 0.0043a,b 0.3562 6 0.0052a
1,6-Diphenyl-1,3,5-hexatriene-propionic acid 0.3585 6 0.0058c 0.3172 6 0.0073 0.3925 6 0.0094a,b 0.3543 6 0.0038a
Relative fluorescence polarization values represent means 6 SEM (n 5 7).
a P , 0.05 versus nonraft of the same mouse strain.
b P , 0.05 versus lipid raft of SCP-2/SCP-x null mice.
c P , 0.05 versus nonraft of SCP-2/SCP-x null mice.
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cholesterol; ii) ABCA1 (57), SR-B1 (58), P-gp (59), and
ABCG1 (54, 60) induce the formation of a mobile choles-
terol pool/domain; iii) ABCA1 (61) and P-gp (59) both
enhance transbilayer cholesterol migration from the cyto-
facial to the exofacial leaflet; and iv) SCP-2 overexpres-
sion enhances cholesterol uptake/esterification (62–64),
whereas SCP-2/SCP-x gene ablation reduces hepatic cho-
lesterol accumulation (65). Thus, by localizing SR-B1,
ABCA1, and P-gp in lipid rafts as well as expressing high
levels of SCP-2, liver hepatocytes are optimally positioned
to mediate the final steps of RCT.
With regard to compensatory changes in these and
other RCT proteins in response to SCP-2/SCP-x gene abla-
tion, plasma membrane transporters (SR-B1, ABCA1, and
P-gp) were not upregulated, but at least one intracellular
transporter (L-FABP) was upregulated, concomitant with
hypersecretion of bile acids and cholesterol (65, 66). Con-
versely, L-FABP gene ablation decreases biliary cholesterol
(67). It should also be noted that potential compensation
for SCP-2/SCP-x gene ablation by the upregulation of
L-FABP (65) described above may also contribute in part
to altered C/P ratios and the modest changes in the fatty
acid profiles of phospholipids in lipid rafts. L-FABP is
known to stimulate the rate-limiting step in microsomal
phospholipid synthesis (i.e., glycerol-3-phosphate acyl-
transferase) in a highly acyl chain-selective manner (68).
The L-FABP-mediated enhancement of phospholipids with
select acyl chain profiles may potentially increase the pool
of these phospholipids available for lipid raft biogenesis.
Third, SCP-2 was significantly associated with hepato-
cyte plasma membrane lipid rafts rather than nonrafts.
The possibility that SCP-2 potentially replaces/compen-
sates at least in part for the absence of caveolin-1 in hepa-
tocytes by facilitating intracellular cholesterol transfer is
supported by both in vitro and cultured cell experiments.
i) SCP-2 differentially enhances cholesterol transfer from
isolated plasma membranes and lipid rafts (fibroblasts and
MDCK cells) to intracellular membrane fractions in vitro
(reviewed in Refs. 1, 12, 13). ii) SCP-2 overexpression in
fibroblasts inhibits cholesterol for efflux to HDL (2). iii)
SCP-2 is associated with lipid rafts but not nonrafts,
suggesting that SCP-2 selectively interacts with an as yet
unknown receptor(s) in hepatocyte lipid rafts. SCP-2 is
known to interact directly with caveolin-1 at the plasma
membrane in caveolin-1-expressing cells (69, 70). How-
ever, hepatocyte homogenates, lipid rafts, and nonrafts
do not contain caveolin-1 (as shown here). iv) Although
direct comparison of caveolin-1 and SCP-2 structures (i.e.,
amino acid sequences) reveals very little similarity (14),
these proteins have in common two structurally based
functional features that are highly important to their po-
tential roles in RCT. Caveolin-1 binds cholesterol in mem-
branes through an as yet unidentified domain (possibly
located in the scaffolding region) and through a cha-
perone complex, again through an as yet unidentified
region. Furthermore, caveolin-1 itself binds/recognizes
the scaffolding domain of other caveolin-1 molecules in
the plasma membrane, consistent with its putative role
in cholesterol trafficking between intracellular sites and
lipid rafts/caveolae at the plasma membrane (reviewed
in Ref. 1). Likewise, SCP-2 also binds cholesterol (re-
viewed in Ref. 1) and interacts directly with caveolin-1,
albeit through a totally different site independent of the
caveolin-1 scaffolding domain (69, 70).
Fourth, on a mass basis (nmol/mg protein), hepatocyte
lipid rafts were found to be highly lipid-rich in total lipid
and phospholipids as well as in the following select lipid
classes (also typically found in lipid rafts/caveolae of pe-
ripheral cells). i) Cholesterol and GM1, lipids commonly
used as lipid raft markers. Cholesterol and sphingolipids
are thought to provide a significant driving force for
lipid raft formation (reviewed in Ref. 1). ii) Phospholipid
classes typically enriched in lipid rafts (especially SM). On
a percentage composition basis, the overall relative order
of prevalence of phospholipid classes shown here in hepa-
tocyte lipid rafts was PC . SM and PE . PI and PS. iii)
Esterified saturated fatty acids were enriched in all lipid
raft phospholipid classes examined, thereby yielding
higher Sat/Unsat ratios for each respective phospholipid
class in lipid rafts than for the same class in nonrafts.
These results are important because cholesterol exhibits
higher affinity for phospholipids with saturated and mono-
unsaturated fatty acids versus polyunsaturated fatty acids
(reviewed in Ref. 71) and because polyunsaturated fatty
acid incorporation into lipid raft phospholipids will
dramatically alter lipid raft lipid distribution and protein
distribution/function (72). iv) The content of polyunsat-
urated fatty acids was extremely low (near 5%) in SM of
lipid rafts. Likewise, the content of polyunsaturated fatty
acids was up to 2-fold lower in PS, PC, PI, and PE located
in lipid rafts than in the same phospholipid class found
in nonrafts isolated from wild-type hepatocytes. These
findings are consistent with model membrane studies of
phase-separated membranes, in which saturated (or mono-
unsaturated) phospholipids partition preferentially into
the cholesterol/sphingolipid-rich phase and polyunsatu-
rated phospholipids are excluded (reviewed in Ref. 71).
The driving force for this separation is thought to be
the poor ability of cholesterol to pack closely with highly
“kinked” conformations of polyunsaturated fatty acid
chains, compared with the relative ease of cholesterol
packing closely with the extended “straight” acyl chains of
saturated fatty acids and, to some degree, with monoun-
saturated fatty acids. v) Hepatocyte lipid rafts were rich in
lipid classes transported through lipid rafts, including
unesterified cholesterol, cholesteryl ester, and unesteri-
fied fatty acid. The presence of these lipids in lipid rafts
was not, however, attributable to copurification of bound
serum lipoproteins or albumin, since Western blotting did
not detect apoA-I, apoB, or albumin in lipid rafts or non-
rafts (data not shown). Instead, these findings may be
rationalized by the fact that cholesterol and cholesteryl
ester, both associated with lipoproteins (HDL), are de-
livered to lipid rafts via HDL binding to SR-B1 (enriched
in lipid rafts by 11-fold). The presence of differential
amounts of cholesterol and cholesteryl esters in lipid rafts
in hepatocyte plasma membranes may be rationalized not
only by the lower membrane solubility of cholesteryl esters
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than cholesterol but also by the fact that the respective
transport pathways for cholesterol and cholesteryl ester
differ (reviewed in Ref. 1). Finally, the presence of un-
esterified fatty acids in lipid rafts correlates with the en-
richment of lipid rafts in proteins that bind and transport
fatty acids across the plasma membrane (52).
Fifth, hepatocyte lipid raft domains were significantly
less fluid than nonrafts. Fluorescence polarizations of es-
sentially all probes examined (DHE, cis-parinaric acid,
NBD-stearic acid, DPH, DPH-TMA, and DPH-Pro) were all
higher in lipid rafts than in nonrafts, indicating that lipid
rafts were more ordered (less fluid) than those of nonrafts.
Furthermore, the fluorescence polarization of DPH was in
the same range as that observed for DPH in the inter-
mediate liquid-ordered phase of model membranes and of
lipid rafts from peripheral cells (fibroblasts) (reviewed in
Refs. 12, 13, 31). Differences in lipid composition sup-
ported the lower fluidity of lipid rafts versus nonrafts from
wild-type hepatocytes. i) Lipid rafts were enriched in cho-
lesterol and sphingolipids, both of which make mem-
branes less fluid as well as spontaneously form lateral
and transbilayer microdomains in model membranes (re-
viewed in Ref. (1). Furthermore, cholesterol regulates the
distribution of proteins either through direct interactions
(73) or by making membranes more rigid (less fluid), a
structure that largely excludes most proteins (reviewed
in Ref. 1). ii) SM of lipid rafts was enriched in saturated
and monounsaturated fatty acyl chains (together consti-
tuting nearly 95% of the total). iii) The other phospho-
lipid classes present in lipid rafts were each enriched in
saturated and monounsaturated acyl chains, resulting in
higher Sat/Unsat ratios, compared with the same phos-
pholipid classes in nonrafts.
Sixth, hepatocyte lipid rafts and nonrafts both exhibited
a transbilayer fluidity gradient in which the inner leaflet
appeared less fluid (more rigid), as determined by fluo-
rescence polarization of leaflet-selective probe molecules.
The molecular basis for the transbilayer fluidity gradient is
primarily attributable to the enrichment of cholesterol in
the cytofacial (inner) leaflet of the plasma membranes of
nucleated cells (reviewed in Refs. 74, 75). The transbilayer
fluidity gradient is essential for the optimal function of
transbilayer transport processes, as shown for the Na1K1-
ATPase and other receptor-mediated processes (reviewed
in Ref. 76).
Seventh, SCP-2/SCP-x gene ablation completely abol-
ished the expression of SCP-2 and significantly altered
hepatocyte lipid raft content and protein distribution,
consistent with the effects of SCP-2/SCP-x gene ablation
on lipid raft lipid composition, fluidity, and transbilayer
structure. i) SCP-2/SCP-x gene ablation increased the
relative proportion of lipid rafts by 1.5-fold compared with
nonrafts, reflective of increased levels of SM detected in
the lipid raft fraction from SCP-2/SCP-x gene-ablated
hepatocytes. Conversely, overexpression of SCP-2 in cul-
tured fibroblasts decreased the proportion of SM in the
lipid raft fraction (12). Sphingolipids, rich in saturated
and monounsaturated fatty acids, spontaneously form
lipid rafts in bilayers containing other phospholipids and
cholesterol (reviewed in Ref. 1), such that treatment
with sphingomyelinase disrupts lipid rafts (reviewed in
Ref. 54). SCP-2 is known to enhance the transfer of
multiple sphingolipid subclasses (SM, glycosphingolipids,
gangliosides, etc.), albeit not equally, between membranes
in vitro (77). Studies of SCP-2-overexpressing liver cell
fibroblasts indicate that SCP-2 has the lowest affinity for
SM compared with any other sphingolipid subclass ex-
amined and preferentially enhances the targeting of other
sphingolipid classes to lipid rafts at the expense of SM
(78). ii) SCP-2/SCP-x gene ablation increased the total
amount of ABCA1, SR-B1, and P-gp protein available at the
hepatocyte plasma membrane for HDL-mediated choles-
terol trafficking by 1.5-fold, but this was attributable
primarily to the increased proportion of lipid rafts rather
than to the increased rigidity of the lipid rafts in SCP-2/
SCP-x gene-ablated hepatocytes. Although the distribution
of ABCA1, SR-B1, and P-gp to lipid rafts is known to de-
pend on the presence of cholesterol, neither choleste-
rol mass nor C/P ratio in lipid rafts was altered by SCP-2/
SCP-x gene ablation (shown here with hepatocytes) or
SCP-2 overexpression (shown with liver cell fibroblasts)
(12). Thus, the amount of lipid raft and, thereby, the
amount of liquid-ordered phase in hepatocyte plasma
membranes, rather than the degree of rigidity of the lipid
raft lipids therein, determined the level of ABCA1, SR-B1,
and P-gp per milligram of protein in lipid rafts. In con-
trast, fluidizing lipid rafts by the incorporation of polyun-
saturated fatty acids significantly reduces the distribution
of caveolin-1 and other proteins into lipid rafts (72, 79).
iii) SCP-2/SCP-x gene ablation increased the rigidity
(decreased fluidity) in hepatocyte lipid rafts, primarily as
a result of the increased content of SM and saturated and
monounsaturated acyl chains, consistent with SCP-2’s abil-
ity to selectively bind/transfer other sphingolipids more
effectively than SM (see above). SCP-2 overexpression in
liver cell fibroblasts dramatically reduces spontaneous and
protein-mediated cholesterol efflux from purified lipid
rafts in vitro (12) and inhibits HDL-mediated cholesterol
efflux from intact living liver cell fibroblasts (2). Although
the effect of increased lipid raft rigidity (decreased
fluidity) on HDL-mediated cholesterol uptake/efflux in
hepatocytes remains to be determined, SCP-2/SCP-x gene
ablation reduced hepatic cholesterol and cholesteryl ester
content (65), whereas SCP-2 overexpression enhanced he-
patic cholesterol accumulation (64). In contrast, incorpo-
ration of polyunsaturated fatty acids displaces cholesterol
from rafts (80), fluidizes lipid rafts (72, 79), increases
ABCA1 degradation (81), and reduces RCT (82). iv) SCP-
2/SCP-x gene ablation abolished the transbilayer fluidity
gradient in lipid rafts of hepatocytes, reflective of the
increased exofacial leaflet rigidity (DPH-TMA) concomi-
tant with decreased cytofacial leaflet rigidity (DPH-Pro).
In wild-type hepatoctyes, the outer (exofacial) leaflet was
more fluid than the inner (cytofacial) leaflet, a result also
observed in the plasma membrane of peripheral nucleated
cell types (41, 83–86) and largely attributable to the en-
richment of cholesterol in the cytofacial leaflet (reviewed in
Ref. 53). Although the effect of SCP-2 gene ablation on
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transbilayer cholesterol distribution is not known, the data
regarding phospholipid distribution may help to explain
the results observed with the SCP-2/SCP-x gene-ablated
hepatocytes. The increased rigidity of the outer leaflet
correlated with the increased lipid raft content of SM, a
lipid that is known to make membrane more rigid and to
be exclusively localized in the exofacial leaflet. In contrast,
the three major phospholipids enriched in the cytofacial
leaflet are PS, PI, and PE. The decreased rigidity of the
cytofacial leaflet of lipid rafts from SCP-2/SCP-x gene-
ablated hepatocytes correlated with the higher DBI of PS
(those of PI and PE were unchanged). Consistent with the
importance of the transbilayer fluidity gradient in receptor-
mediated transbilayer transport processes (reviewed in
Ref. 76), SCP-2 gene ablation reduces cholesterol absorp-
tion and alters biliary cholesterol excretion in liver (87).
In contrast, SCP-2 overexpression in cultured fibroblasts
alters the structural properties of lipid rafts in plasma mem-
branes (12), enhances HDL-mediated cholesterol uptake
for esterification (63), and inhibits cholesterol efflux (2),
whereas SCP-2 overexpression in mice enhances hepatic
cholesterol accumulation (64). Thus, an important role of
SCP-2 within the cell appears to be ensuring the dynamic
flow of cholesterol into and out of lipid rafts with cross-talk
between SCP-2 and the RCT proteins involved in trans-
membrane cholesterol transfer and uptake/efflux through
a dynamic cholesterol pool within lipid rafts. Consistent
with this possibility, studies with liver cell fibroblast lipid
rafts and nonrafts show that SCP-2 increases the size of
the rapidly transferable sterol domain by 4.2-fold in lipid
rafts, but not in nonrafts, in vitro (12).
In summary, the data presented here with SCP-2/SCP-x
gene-ablated mice and an affinity chromatography method
(detergent-free, high-pH carbonate buffer-free) to simul-
taneously isolate lipid rafts and nonrafts show for the first
time the existence of both lipid rafts and nonrafts in high
proportion (1:2) in the plasma membrane of primary he-
patocytes. Biochemical and biophysical characterization
further revealed that primary hepatocyte lipid rafts exhib-
ited a unique lipid distribution consistent with preferential
interaction of cholesterol with select phospholipid classes,
a structure consistent with an intermediate liquid-ordered
phase, as well as a transbilayer fluidity gradient, enrichment
in proteins mediating HDL-cholesterol trafficking, and
regulation of these properties by SCP-2 expression.
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